Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-25,000
Closed -$16.7K 113
2024
Q2
$16.7K Hold
25,000
0.01% 109
2024
Q1
$32.5K Hold
25,000
0.01% 113
2023
Q4
$14.3K Hold
25,000
0.01% 105
2023
Q3
$18.9K Hold
25,000
0.01% 107
2023
Q2
$18.3K Buy
+25,000
New +$23.2K 0.01% 111
2023
Q1
Sell
-10,000
Closed -$9.61K 101
2022
Q4
$9.61K Hold
10,000
0.01% 81
2022
Q3
$31K Hold
10,000
0.02% 92
2022
Q2
$35K Hold
10,000
0.02% 80
2022
Q1
$50.4K Hold
10,000
0.02% 156
2021
Q4
$62.7K Hold
10,000
0.02% 158
2021
Q3
$79.5K Hold
10,000
0.03% 143
2021
Q2
$74.9K Buy
+10,000
New +$69.8K 0.03% 155
2020
Q4
$57.1K Hold
10,000
0.03% 157
2020
Q3
$66.5K Buy
+10,000
New +$89.1K 0.03% 150
2020
Q2
Sell
-10,000
Closed -$17.7K 291
2020
Q1
$17.7K Hold
10,000
0.01% 196
2019
Q4
$3.5K Hold
10,000
﹤0.01% 266
2019
Q3
$3.59K Hold
10,000
﹤0.01% 291
2019
Q2
$6.7K Hold
10,000
﹤0.01% 278
2019
Q1
$19.4K Hold
10,000
0.01% 229
2018
Q4
$18.8K Hold
10,000
0.02% 164
2018
Q3
$28.5K Hold
10,000
0.02% 148
2018
Q2
$30.3K Hold
10,000
0.02% 137
2018
Q1
$53.1K Buy
+10,000
New +$64.6K 0.04% 111

Other funds holding VXRT

RPg Family Wealth Advisory's VXRT Position: Q3 2024 in Review

RPg Family Wealth Advisory sold out of Vaxart (VXRT) in Q3 2024, closing a stake of 25,000 shares — an estimated $16.7K sold.

RPg Family Wealth Advisory first reported a position in VXRT in Q1 2018 and held it in 23 quarters. The position peaked at $79.5K in Q3 2021. 100 funds tracked by Wall St. Rank hold VXRT as of Q3 2024.

  • RPg Family Wealth Advisory reported no remaining Vaxart position as of Q3 2024 after selling out during the quarter.
  • RPg Family Wealth Advisory sold 25,000 Vaxart shares in Q3 2024, an estimated $16.7K.
  • RPg Family Wealth Advisory first reported a position in Vaxart in Q1 2018 and held it in 23 quarters.
  • RPg Family Wealth Advisory's Vaxart position peaked at $79.5K in Q3 2021.
  • 100 funds tracked by Wall St. Rank held Vaxart as of Q3 2024.

Based on RPg Family Wealth Advisory's 13F filing for Q3 2024, filed 5 Nov 2024.